Welcome to the FSU Institute for Pediatric Rare Diseases at the Florida State University College of Medicine, a ground-breaking program of the FSU Health initiative. Our mission is to transform the lives of children affected by rare diseases through research, education, diagnosis, and clinical care.
Atypical Teratoid Rhabdoid Tumor:
An IPRD-funded research team, led by Qing-Xiang Amy Sang, Ph.D., at the FSU Department of Chemistry and Biochemistry, is making groundbreaking progress in research on the treatment of rare pediatric brain tumors, including Atypical Teratoid Rhabdoid Tumor (ATRT) and Diffuse Intrinsic Pontine Glioma (DIPG). Sang’s lab is pioneering the development of innovative therapies offering new hope for ATRT and DIPG patients.
Drishty Sarker, Yue Xue, and Sonia Kiran, PhD students in the Sang lab present their research on gene expression patterns in ATRT and DIPG and cell-cell interactions within the tumor microenvironment. The team’s work includes contributions from other students, including Faiza Mahmud, Uvindu Thilanka Dasili Wickramasinghe, Jonathan Jocelyn, Marian Gonzalez, Sophia Martinez, and Fiona Dininger.
|
 |
 |
 |
 |
|
Contact Information: IPRD@med.fsu.edu
